Upon inhibition of TARBP2 expression, ACC cells showed a significant reduction of cell viability over time (Fig. 4A) and a markedly increase (∼30%) of cell death (Fig. 4B) in comparison with negative control cells. This evidence concerns the gene TARBP2 and adrenal cortex carcinoma.